Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,571 | -31,853 | -21,770 | -11,209 | -51,898 |
| Depreciation Amortization | 1,345 | 877 | 594 | 313 | 1,253 |
| Accounts payable and accrued liabilities | -366 | -717 | 2,827 | 2,999 | -3,331 |
| Other Working Capital | -3,445 | -4,884 | -705 | -354 | 3,959 |
| Other Operating Activity | 5,085 | 6,422 | -15 | -1,868 | 12,949 |
| Operating Cash Flow | $-36,952 | $-30,155 | $-19,069 | $-10,119 | $-37,068 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | N/A | N/A | N/A | -84 |
| Investing Cash Flow | $-16 | $N/A | $0 | $N/A | $-84 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,866 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 9,866 | 9,866 | N/A | 19,727 |
| Common Stock Issued | 26,829 | 21,966 | 12,394 | 10,328 | 23,143 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -549 |
| Financing Cash Flow | $36,695 | $31,832 | $22,260 | $10,328 | $42,321 |
| Exchange Rate Effect | 48 | 144 | 105 | 31 | 22 |
| Beginning Cash Position | 19,492 | 19,492 | 19,492 | 19,492 | 14,301 |
| End Cash Position | 19,267 | 21,313 | 22,788 | 19,732 | 19,492 |
| Net Cash Flow | $-225 | $1,821 | $3,296 | $240 | $5,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,952 | -30,155 | -19,069 | -10,119 | -37,068 |
| Capital Expenditure | -16 | N/A | N/A | N/A | -87 |
| Free Cash Flow | -36,968 | -30,155 | -19,069 | -10,119 | -37,155 |